CTOs on the Move

ClearMedical

www.clearmedical.com

 
ClearMedical Inc. is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Integra Spine

Integra Spine is a Akron, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Massachusetts Hospital Association

Massachusetts Hospital Association is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Burlington, MA. To find more information about Massachusetts Hospital Association, please visit www.mhalink.org

Clinique Laboratories, LLC

Clinique Laboratories, LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about Clinique Laboratories, LLC, please visit www.clinique.com

Davis Memorial Hospital

At Davis Health System, our goal is excellence—and we have the support of nearly 1,000 healthcare professionals in reaching that goal. We are committed to providing patient-friendly, quality healthcare to our communities in five regional counties. We do it by offering technology that`s equal to that of larger hospitals, expertise that is backed by continuing education and services that focus on the specific healthcare needs of our friends and neighbors. As impressive as our facilities, equipment and credentials are, it`s the caring nature of our professionals that defines us.

Ritter Pharmaceuticals

Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.